GB0412194D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0412194D0
GB0412194D0 GB0412194A GB0412194A GB0412194D0 GB 0412194 D0 GB0412194 D0 GB 0412194D0 GB 0412194 A GB0412194 A GB 0412194A GB 0412194 A GB0412194 A GB 0412194A GB 0412194 D0 GB0412194 D0 GB 0412194D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0412194A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0412194A priority Critical patent/GB0412194D0/en
Publication of GB0412194D0 publication Critical patent/GB0412194D0/en
Priority to CA002542522A priority patent/CA2542522A1/en
Priority to KR1020067009627A priority patent/KR20060123164A/en
Priority to AU2004283137A priority patent/AU2004283137A1/en
Priority to US10/595,390 priority patent/US7579349B2/en
Priority to DE602004022187T priority patent/DE602004022187D1/en
Priority to EP04768838A priority patent/EP1678169B1/en
Priority to BRPI0415398-7A priority patent/BRPI0415398A/en
Priority to JP2006534814A priority patent/JP2007510626A/en
Priority to PCT/GB2004/004307 priority patent/WO2005040159A1/en
Priority to ES04768838T priority patent/ES2328820T3/en
Priority to TW093131214A priority patent/TW200530229A/en
Priority to UY28565A priority patent/UY28565A1/en
Priority to ARP040103757A priority patent/AR046338A1/en
Priority to SA04250338A priority patent/SA04250338B1/en
Priority to IL174989A priority patent/IL174989A0/en
Priority to NO20062130A priority patent/NO20062130L/en
Ceased legal-status Critical Current

Links

GB0412194A 2003-10-17 2004-06-02 Novel compounds Ceased GB0412194D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GB0412194A GB0412194D0 (en) 2004-06-02 2004-06-02 Novel compounds
KR1020067009627A KR20060123164A (en) 2003-10-17 2004-10-11 4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer
JP2006534814A JP2007510626A (en) 2003-10-17 2004-10-11 4- (Pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
ES04768838T ES2328820T3 (en) 2003-10-17 2004-10-11 DERIVATIVES OF 4- (PIRAZOL-3-ILAMINO) PYRIMIDINE FOR USE IN CANCER TREATMENT.
AU2004283137A AU2004283137A1 (en) 2003-10-17 2004-10-11 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
US10/595,390 US7579349B2 (en) 2003-10-17 2004-10-11 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
DE602004022187T DE602004022187D1 (en) 2003-10-17 2004-10-11 4- (PYRAZOL-3-YLAMINO) PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER
EP04768838A EP1678169B1 (en) 2003-10-17 2004-10-11 4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer
BRPI0415398-7A BRPI0415398A (en) 2003-10-17 2004-10-11 compound, pharmaceutical composition, process for preparing it, use of a compound, method of treating cancer, and, process for preparing a compound
CA002542522A CA2542522A1 (en) 2003-10-17 2004-10-11 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
PCT/GB2004/004307 WO2005040159A1 (en) 2003-10-17 2004-10-11 4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
TW093131214A TW200530229A (en) 2003-10-17 2004-10-14 Novel compounds
ARP040103757A AR046338A1 (en) 2003-10-17 2004-10-15 COMPOUNDS DERIVED FROM PYRIMIDINE, PROCESSES FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF PROLIFERATIVE DISEASES
UY28565A UY28565A1 (en) 2003-10-17 2004-10-15 NEW COMPOUNDS
SA04250338A SA04250338B1 (en) 2003-10-17 2004-10-16 4- (pyrazol-3-ylamino0 pyrimidine derivatives for use in the treatment of cancer
IL174989A IL174989A0 (en) 2003-10-17 2006-04-11 4-(pyrazol-3-ylamino)pyrimidine derivatives for use in the treatment of cancer
NO20062130A NO20062130L (en) 2003-10-17 2006-05-12 4- (pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0412194A GB0412194D0 (en) 2004-06-02 2004-06-02 Novel compounds

Publications (1)

Publication Number Publication Date
GB0412194D0 true GB0412194D0 (en) 2004-07-07

Family

ID=32696457

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0412194A Ceased GB0412194D0 (en) 2003-10-17 2004-06-02 Novel compounds

Country Status (1)

Country Link
GB (1) GB0412194D0 (en)

Similar Documents

Publication Publication Date Title
GB0400812D0 (en) Novel compounds
EP1718638A4 (en) Novel compounds
GB0409744D0 (en) Novel compounds
GB0405628D0 (en) Novel compounds
GB0402140D0 (en) Novel compounds
GB0402496D0 (en) Novel compounds
GB0402357D0 (en) Novel compounds
EP1805132A4 (en) Novel compounds
EP1796793A4 (en) Novel compounds
GB0408083D0 (en) Novel compounds
GB0402812D0 (en) Novel compounds
GB0402355D0 (en) Novel compounds
GB0402356D0 (en) Novel compounds
GB0404105D0 (en) Novel compounds
GB0402380D0 (en) Novel compounds
GB0402114D0 (en) Novel compounds
GB0400461D0 (en) Novel compounds
GB0402144D0 (en) Novel compounds
GB0402145D0 (en) Novel compounds
GB0402134D0 (en) Novel compounds
GB0402115D0 (en) Novel compounds
GB0402110D0 (en) Novel compounds
GB0401727D0 (en) Novel compounds
GB0400901D0 (en) Novel compounds
GB0400885D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)